For the Quarter Ending June 2026
Clofazimine Prices in North America
- In the United States, the Clofazimine Price Index rose quarter-over-quarter in Q2 2026, driven by producer inflation and strengthening demand.
- Clofazimine production costs increased in Q2 2026, driven by 5.5% PPI and 3.5% CPI year-over-year rises in June 2026.
- Demand for Clofazimine strengthened in Q2 2026 due to a rise in US leprosy cases and sustained tuberculosis treatment demand.
- Global pharmaceutical raw material costs continued to rise in Q2 2026, contributing to upward Clofazimine Price Forecast.
- US industrial production grew 0.7% year-over-year in June 2026; retail sales rose 6.9% year-over-year in May 2026, showing mixed signals.
- A 4.2% unemployment rate in June 2026 indicated a tight labor market, increasing wage pressures for producers.
- Consumer confidence at 91.2 in June 2026 suggested caution, influencing healthcare investment indirectly.
- Shipping container rates from East Asia to the US surged in June 2026, elevating Clofazimine import costs.
Why did the price of Clofazimine change in June 2026 in North America?
- Producer Price Index (PPI) year-over-year rose 5.5% in June 2026, increasing Clofazimine raw material and manufacturing costs.
- Consumer Price Index (CPI) year-over-year rose 3.5% in June 2026, raising operational expenses for producers.
- Shipping container rates from East Asia to the US surged in June 2026, elevating import costs for Clofazimine components.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index fell in Q2 2026, driven by global oversupply and weakened general consumption in May 2026.
- Clofazimine production costs increased in Q2 2026, due to a 4.1% rise in producer prices in June 2026.
- The demand outlook for Clofazimine was impacted by weakened general consumption in China during May 2026.
- China's Manufacturing Index expanded in June 2026, indicating robust industrial activity supporting chemical supply.
- Industrial production in China rose 5.3% year-over-year in June 2026, ensuring stable raw material availability.
- Global oversupply of petrochemicals continued in 2026, intensifying pressure on chemical market supply and demand.
- Retail sales growth was low at 1.0% year-over-year in June 2026, reflecting persistent consumer caution.
- Petrochemical supply from the Middle East to Asia normalized in June 2026, alleviating previous regional shortages.
- Consumer prices remained stable with a 1.0% year-over-year CPI in June 2026, supporting a predictable cost environment.
Why did the price of Clofazimine change in June 2026 in APAC?
- Producer prices rose 4.1% in June 2026, increasing Clofazimine production costs in China.
- Global oversupply of petrochemicals and increased capacity intensified market competition in 2026.
- Weakened general consumption in China during May 2026 impacted overall chemical demand.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index rose quarter-over-quarter in Q2 2026, driven by elevated production costs and robust pharmaceutical demand.
- Clofazimine production costs increased due to a 2.2% rise in producer prices year-on-year in May 2026, impacting input materials.
- Naphtha feedstock costs climbed sharply year-on-year in June 2026, contributing to higher Clofazimine production expenses.
- Demand for pharmaceuticals in Germany strengthened during Q2 2026, supported by an aging population.
- Germany's Manufacturing Index was contracting in June 2026, indicating a slowdown in broader industrial activity.
- Consumer Price Index rose 2.3% year-on-year in June 2026, reflecting general inflation impacting operational costs.
- Industrial production in Germany remained stagnant year-on-year in May 2026, suggesting a challenging manufacturing environment.
- Clofazimine demand outlook was supported by 1.8% retail sales growth year-on-year in May 2026, bolstering healthcare funding.
- Weak consumer confidence, at -14.6 in June 2026, indicated potential headwinds for healthcare funding and procurement.
Why did the price of Clofazimine change in June 2026 in Europe?
- Elevated input costs, including a 2.2% PPI increase in May 2026, pressured Clofazimine production expenses.
- Naphtha feedstock costs climbed sharply in June 2026, directly impacting Clofazimine manufacturing expenditures.
- Strengthened pharmaceutical demand in Q2 2026, despite broader industrial contraction, supported Clofazimine price increases.
For the Quarter Ending March 2026
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index fell quarter-over-quarter in Q1 2026, driven by plummeting upstream benzene feedstock costs.
- The Clofazimine Production Cost Trend faced downward pressure in March 2026, despite a 4.0% YoY PPI increase.
- A 3.3% YoY CPI rise in March 2026 increased transportation expenses for distributing pharmaceutical APIs like Clofazimine.
- The Clofazimine Demand Outlook remained supported in March 2026 by resilient retail sales growth of 4.0% YoY.
- A stable 4.3% unemployment rate in March 2026 maintained patient access to specialty medications, supporting Clofazimine consumption.
- Modest industrial production growth of 0.7% YoY in March 2026 indicated energy constraints in pharmaceutical reactor processes.
- The Manufacturing Index expanded in March 2026, ensuring steady production of complex APIs despite global supply disruptions.
- Benzene feedstock demand weakened in March 2026, while Brent crude oil spot prices surged amid regional conflicts.
- The Clofazimine Price Forecast reflected stabilization in Q1 2026 as global chemical supply chains faced tightening pressures.
Why did the price of Clofazimine change in March 2026 in North America?
- Plummeting upstream benzene feedstock costs in March 2026 directly reduced the primary chemical synthesis expenses.
- Overall chemical sector demand softened in Q1 2026 as downstream derivative consumption remained notably sluggish.
- Global chemical supply chains faced tightening pressures in March 2026 due to Middle East conflicts.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- The Clofazimine Production Cost Trend increased during March 2026 as the Producer Price Index rose 0.5% year-over-year.
- The Clofazimine Demand Outlook remained stable in March 2026, supported by a mild 1.0% year-over-year Consumer Price Index increase.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring abundant upstream chemical precursors for the Clofazimine Price Index.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, shifting Clofazimine procurement to public programs.
- The Manufacturing Index expanded in March 2026, while consumer confidence hit 91.6 in February 2026, insulating essential drugs.
- Naphtha and benzene feedstock costs surged during Q1 2026 due to severe Middle East supply chain disruptions.
- Chinese chemical export volumes surged in March 2026, establishing a firm baseline for the Clofazimine Price Forecast.
Why did the price of Clofazimine change in March 2026 in APAC?
- Upstream naphtha and benzene feedstock costs surged significantly during Q1 2026 due to supply shocks.
- Domestic chemical feedstock supply tightened in March 2026 as refiners prioritized fuel over chemical production.
- Seaborne naphtha availability plummeted throughout Q1 2026 following major shipping disruptions in the Middle East.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell quarter-over-quarter in Q1 2026, driven by plummeting pharmaceutical demand.
- Pharmaceutical production plummeted in January 2026 and reflected weakened demand for active ingredients including Clofazimine.
- The Clofazimine Demand Outlook weakened as pharmaceutical sector output continued to decline in February 2026.
- The Clofazimine Production Cost Trend eased as producer prices declined by 0.2% in March 2026.
- Consumer inflation rose 2.7% in March 2026 and increased operational costs for regional API manufacturers.
- The Manufacturing Index expanded in March 2026, while industrial production stagnated at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment stabilized at 4.2% in February 2026, which supported procurement.
- Consumer confidence at -24.7 in March 2026 constrained private spending and softened the Clofazimine Price Forecast.
Why did the price of Clofazimine change in March 2026 in Europe?
- Pharmaceutical production plummeted in January 2026 and significantly reduced overall consumption of active pharmaceutical ingredients.
- Producer prices declined by 0.2% in March 2026 and eased upstream raw material costs regionally.
- Negative consumer confidence in March 2026 constrained private healthcare spending and suppressed overall market demand.
For the Quarter Ending December 2025
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Production costs increased due to a 3.0% year-over-year PPI rise in November 2025, impacting inputs.
- Overall inflation, with CPI up 2.7% year-over-year in December 2025, elevated manufacturing expenses.
- Labor costs faced upward pressure from a 4.4% unemployment rate in December 2025.
- Electricity costs for manufacturing operations increased in October and November 2025, raising expenses.
- US manufacturing output declined in Q4 2025, despite 2.0% industrial production rise in December.
- Henry Hub natural gas spot prices strengthened in Q4 2025, driven by increased cold snap consumption.
- US business inventories increased in October 2025, potentially influencing future Clofazimine supply dynamics.
- Demand for Clofazimine remained stable in Q4 2025, driven by medical necessity, not consumer trends.
Why did the price of Clofazimine change in December 2025 in North America?
- Rising producer input costs, with PPI up 3.0% year-over-year in November 2025, raised manufacturing costs.
- Higher overall inflation, shown by a 2.7% year-over-year CPI in December 2025, elevated operational costs.
- Increased electricity costs for manufacturing in October and November 2025 contributed to higher production expenses.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index remained stable quarter-over-quarter in Q4 2025, influenced by declining producer costs.
- Clofazimine production costs decreased in Q4 2025, as the Producer Price Index fell by -1.9% year-on-year in December.
- The Manufacturing Index expanded in December 2025, alongside a 5.2% Industrial Production increase, supporting supply.
- Clofazimine demand outlook was stable, despite weak consumer spending with Retail Sales rising only 0.9% year-on-year in December.
- Crude oil prices generally declined in 2025, contributing to lower energy and feedstock expenses for manufacturing.
- China's chemical sector experienced supply expansion in 2025 due to continuous new production capacity releases.
- The urban unemployment rate remained moderate at 5.1% in December 2025, supporting stable labor costs.
- Biopharma and High-Performance Medical Devices sectors met or exceeded performance targets in November 2025.
Why did the price of Clofazimine change in December 2025 in APAC?
- Producer Price Index declined by -1.9% year-on-year in December 2025, reducing Clofazimine manufacturing input costs.
- Industrial Production increased by 5.2% year-on-year in December 2025, supporting efficient Clofazimine supply.
- Cooled consumer sentiment in Q4 2025 indirectly influenced government healthcare budgets and market stability.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell quarter-over-quarter in Q4 2025, influenced by decreasing producer prices in December 2025.
- Clofazimine production costs declined as the Producer Price Index (PPI) fell by 2.5% year-on-year in December 2025.
- Overall goods inflation eased in Germany during December 2025, contributing to a more stable cost environment.
- European natural gas prices remained elevated in Q4 2025, despite year-end declines, impacting some production expenses.
- The Manufacturing Index for Germany was contracting in December 2025, signaling broader economic activity challenges.
- Clofazimine demand outlook faced headwinds from pessimistic consumer confidence at -17.5 in December 2025.
- Industrial production in Germany rose robustly in October 2025 and continued to rise in November 2025.
- The German pharmaceutical market experienced growth in Q4 2025, supporting demand for essential medicines.
- Clofazimine price forecast suggests continued stability or slight downward pressure due to easing input costs in Q4 2025.
Why did the price of Clofazimine change in December 2025 in Europe?
- Producer Price Index (PPI) declined by 2.5% year-on-year in December 2025, reducing manufacturing input costs.
- Overall goods inflation eased in December 2025, contributing to lower operational expenses.
- Pessimistic consumer confidence at -17.5 in December 2025 indirectly impacted healthcare procurement.
For the Quarter Ending September 2025
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index rose quarter-over-quarter in Q3 2025, driven by accelerating production costs.
- Clofazimine production costs accelerated in Q3 2025, influenced by a 2.6% PPI increase in August 2025.
- Demand for Clofazimine weakened in major customer markets during Q3 2025, with new orders declining.
- The Clofazimine Price Forecast indicates continued upward pressure due to rising input costs and tariffs.
- Overall chemical manufacturing activity contracted in Q3 2025, aligning with a 0.1% industrial production increase.
- General inflation, with CPI rising 3.0% in September 2025, increased non-chemical raw material and labor expenses.
- A 4.3% unemployment rate in September 2025 contributed to higher labor costs for Clofazimine manufacturers.
- Inventories across the chemical industry shrank in Q3 2025 due to accelerating destocking activities.
- Foreign orders for US chemical manufacturers dropped in Q3 2025, reflecting weakened international demand.
Why did the price of Clofazimine change in September 2025 in North America?
- Production costs accelerated in Q3 2025, driven by a 2.6% PPI increase in August 2025.
- General inflation, with CPI rising 3.0% in September 2025, increased non-chemical raw material and labor costs.
- US tariffs exacerbated strain on the chemical sector in Q3 2025, adding to manufacturing expenses.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and global feedstock oversupply.
- Clofazimine production costs decreased in Q3 2025, influenced by a -2.3% year-on-year decline in producer prices in September 2025.
- Demand for Clofazimine active pharmaceutical ingredients surged in August and September 2025, aligning with inventory levels.
- The Manufacturing Index contracted in September 2025, reflecting a broader slowdown in China's manufacturing sector.
- Overall chemical feedstock prices experienced pressure due to global oversupply throughout Q3 2025, impacting production expenses.
- Industrial production grew by 6.5% year-on-year in September 2025, supporting overall economic stability and public health funding.
- Retail sales increased by 3.0% year-on-year in September 2025, contributing to government revenues for public health programs.
- Consumer confidence remained pessimistic in September 2025, with an index value of 89.6, signaling broader economic concerns.
- Trade flows for chemical products faced disruptions in Q3 2025 due to ongoing tariff uncertainties and protectionist measures.
Why did the price of Clofazimine change in September 2025 in APAC?
- Producer prices declined -2.3% year-on-year in September 2025, reducing Clofazimine manufacturing costs.
- Overall chemical feedstock prices faced pressure from global oversupply throughout Q3 2025.
- Despite surging API demand in August-September 2025, broader deflationary pressures influenced pricing.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell in Q3 2025, due to declining input costs and weakening demand.
- Clofazimine production costs declined in Q3 2025, supported by a -1.7% PPI in September 2025.
- Demand for Clofazimine faced headwinds in Q3 2025 from -1.0% industrial production in September 2025.
- The Clofazimine price trend remained pressured by the German chemical and pharmaceutical industry's declining prices in Q3 2025.
- Elevated electricity prices and 2.4% CPI in September 2025 impacted Clofazimine operational costs.
- Benzene feedstock costs sharply declined in September 2025, lowering production expenses for Clofazimine.
- Germany's Manufacturing Index contracted in September 2025, signaling a slowdown in overall industrial activity.
- Subdued consumer spending (0.8% retail sales) and -23.6 consumer confidence in September 2025 indirectly pressured demand.
- A 3.9% unemployment rate in September 2025 indicated stable labor markets, potentially influencing wage costs.
Why did the price of Clofazimine change in September 2025 in Europe?
- Declining PPI (-1.7%) in September 2025 reduced Clofazimine input costs for German producers.
- Benzene feedstock costs sharply declined in September 2025, easing Clofazimine production expenses.
- Germany's Manufacturing Index contracted in September 2025, signaling broader industrial slowdown affecting demand.
